PLx Pharma Inc (PLXP)

PLx Pharma Stock Analysis & Ratings

PLXP Stock Chart & Stats

Day’s Range$2.77 - $3.13
52-Week Range$1.93 - $21.50
Previous Close$2.92
Average Volume (3M)247.25K
Market Cap$83.17M
P/E Ratio-1.4
Next EarningsAug 12, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score5
EPS (TTM)-2.19



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was PLx Pharma’s price range in the past 12 months?
PLx Pharma lowest stock price was $1.93 and its highest was $21.50 in the past 12 months.
    What is PLx Pharma’s market cap?
    PLx Pharma’s market cap is $83.17M.
      What is PLx Pharma’s price target?
      The average price target for PLx Pharma is $21.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $21.00 ,the lowest forecast is $21.00. The average price target represents 595.36% Increase from the current price of $3.02.
        What do analysts say about PLx Pharma?
        PLx Pharma’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is PLx Pharma’s upcoming earnings report date?
          PLx Pharma’s upcoming earnings report date is Aug 12, 2022 which is in 86 days.
            How were PLx Pharma’s earnings last quarter?
            PLx Pharma released its earnings results on May 13, 2022. The company reported -$0.39 earnings per share for the quarter, beating the consensus estimate of -$0.723 by $0.333.
              Is PLx Pharma overvalued?
              According to Wall Street analysts PLx Pharma’s price is currently Undervalued.
                Does PLx Pharma pay dividends?
                PLx Pharma does not currently pay dividends.
                What is PLx Pharma’s EPS estimate?
                PLx Pharma’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does PLx Pharma have?
                PLx Pharma has 27,540,000 shares outstanding.
                  What happened to PLx Pharma’s price movement after its last earnings report?
                  PLx Pharma reported an EPS of -$0.39 in its last earnings report, beating expectations of -$0.723. Following the earnings report the stock price went up 27.586%.
                    Which hedge fund is a major shareholder of PLx Pharma?
                    Among the largest hedge funds holding PLx Pharma’s share is Perceptive Advisors LLC. It holds PLx Pharma’s shares valued at N/A.


                      PLx Pharma Stock Analysis

                      The PLx Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      PLx Pharma Inc

                      PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development of clinically validated and patent-protected PLxGuard delivery system. Its products include Vazalore 325 mg and PL1200 Ibuprofen 200 mg. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Houston, TX.

                      Similar Stocks
                      Price & Change
                      Eledon Pharmaceuticals
                      Avenue Therapeutics
                      Alpine Immune Sciences

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis